OKILYS suite OKILYS website OKILYS CTMS OKILYS eTMF coming soon A suite of tools to run your clinical trials from A to Z

Highlights

Career highlights

A few concrete successes that illustrate the way we work:
anticipate, structure and deliver — from design to close-out.

Full set-up of a Clinical Oversight activity

Clinical Oversight Manager · since 2025Key achievement

End-to-end design and roll-out of the sponsor-side oversight activity.

  • Documentation framework: Clinical Oversight Plan, update of all internal SOPs and Supportive Documents, documents to conduct Oversight Monitoring Visits
  • Quality metrics tracking tools: CRA monitoring quality, site quality, EDC entry & queries, SAE notification timelines, overall safety follow-up
  • Escalation paths to project management and governance set-up
  • Concrete actions triggered: Oversight Monitoring Visits, investigations with the CRO and the sites, dedicated report reviews on top of routine review

Start-Up driven end to end for 11 sites

SSU & Contract Specialist · 2024-2025

Large-scale study under EU-CTR — phases I-II, oncology and ophthalmology.

  • The entire Start-Up activity driven through to delivery — full preparation and submissions (steps 3 and 4 of our journey)
  • Essential documents, contracts and budgets
  • 11 sites activated within timelines

Resolving a budget impasse in oncology

SSU & Contract Specialist · 2023-2024

Complex project (Convention Unique, EU regulations): 50% of the 16 sites refused the sponsor-approved budget — site activation was already delayed when the file was handed over.

  • Budget grid revised for 8 sites, protocol amendment corrections integrated
  • Renegotiation with all parties
  • Situation fully untangled: amended contracts signed within a timeframe compatible with the study timeline

Turnkey CNIL declaration strategy

SSU & Contract Specialist · 2023

CNIL declarations to be secured while respecting the delegation of authority between CRO and sponsor.

  • Reference methodologies declaration strategy developed and implemented
  • Step-by-step guidance enabling SSU colleagues to submit in line with regulatory and contractual requirements

Regulatory qualification of a data-only study

SSU & Contract Specialist · 2021

French study involving patient data only, with no internal expertise available.

  • Regulatory research and discussions with the French authorities: RNIPH classification confirmed
  • Guidance to the sponsor and the team — regulatory pathway and Health Data Hub compliance secured

Monitoring recognised, assignment after assignment

Senior CRA & Clinical Trial Lead · 2014-2024

Ten years of monitoring at CROs and sponsors, from rare diseases to oncology.

  • Praised by sponsor-side teams: responsiveness, autonomy, quality of deliverables
  • Recommended on LinkedIn for monitoring expertise
  • Visit reports singled out by the Clinical Operations Lead and the sponsor
  • Team Lead responsibilities delegated and delivered successfully
  • Recognised for knowledge sharing and managing pressure, including on a demanding oncology trial
Meet the founder Contact us